Skip to main content
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1990;17(3):216–218.

A 4-Year Experience with the Björk-Shiley Monostrut Valve

Guy Maddern 1, Hugh S Paterson 1, David R Craddock 1, Iain K Ross 1, John Stubberfield 1, Stefano Picozzi 1, Phillip B Leppard 1
PMCID: PMC324919  PMID: 15227173

Abstract

We reviewed 314 consecutive patients in whom a Björk-Shiley Monostrut aortic valve prosthesis was inserted by our cardiothoracic surgical unit from June 1982 through June 1986. The group comprised 220 males (70%) and 94 females (30%), with a mean age of 60 years (range, 5 to 83 years). Two hundred ninety-six patients (94%) received an aortic prosthesis alone, and the other 18 (6%) received both an aortic Monostrut valve and a Starr-Edwards mitral valve prosthesis. In each case, preoperative data were collected prospectively, and a questionnaire was sent at the time of follow-up. The median follow-up period was 23 months (range, 0 to 46 months); 6 (2%) of the patients were lost to follow-up.

In the remaining 308 cases, there were 20 deaths (6.5%), 8 of which occurred within approximately 1 month after operation. There were no known instances of valve failure. One death occurred in the group that underwent double-valve replacement. Valve endocarditis accounted for 2 late deaths. With respect to preoperative dyspnea, 59 (19%) of the patients were in New York Heart Association functional Class I, 74 (24%) were in Class II, 138 (45%) were in Class III, and 37 (12%) were in Class IV. Postoperatively, there were 247 patients (80%) in Class I, 43 (14%) in Class II, 15 (5%) in Class III, and 3 (1%) in Class IV (p < 0.0001).

All of the patients received postoperative anticoagulant therapy; 3.4% per year were subsequently readmitted for bleeding problems. Thromboembolic events necessitating hospitalization occurred in 3.0% of the patients per year.

On the basis of these results, our early experience with the Björk-Shiley Monostrut valve in the aortic position has been satisfactory, with an acceptable rate of complications and no documented valve failures. (Texas Heart Institute Journal 1990;17:216-8)

Keywords: Björk-Shiley Monostrut valve

Keywords: aortic valve

Keywords: heart valve prosthesis

Full text

PDF
216

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Björk V. O., Lindblom D., Henze A. The monostrut strength. Scand J Thorac Cardiovasc Surg. 1985;19(1):13–19. doi: 10.3109/14017438509102815. [DOI] [PubMed] [Google Scholar]
  2. Björk V. O. The optimal opening angle of the Björk-Shiley tilting disc valve prosthesis. Scand J Thorac Cardiovasc Surg. 1981;15(3):223–227. doi: 10.3109/14017438109100577. [DOI] [PubMed] [Google Scholar]
  3. Lindblom D., Björk V. O., Semb B. K. Mechanical failure of the Björk-Shiley valve. Incidence, clinical presentation, and management. J Thorac Cardiovasc Surg. 1986 Nov;92(5):894–907. [PubMed] [Google Scholar]
  4. Ostermeyer J., Horstkotte D., Bennett J., Huysmans H., Lindblom D., Olin C., Orinius E., Semb G. The Björk-Shiley 70 degree convexo-concave prosthesis strut fracture problem (present state of information). Thorac Cardiovasc Surg. 1987 Apr;35(2):71–77. doi: 10.1055/s-2007-1020200. [DOI] [PubMed] [Google Scholar]
  5. Thulin L. I., Bain W. H., Huysmans H. H., van Ingen G., Prieto I., Basile F., Lindblom D. A., Olin C. L. Heart valve replacement with the Björk-Shiley Monostrut valve: early results of a multicenter clinical investigation. Ann Thorac Surg. 1988 Feb;45(2):164–170. doi: 10.1016/s0003-4975(10)62430-7. [DOI] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES